ATE65912T1 - Arzneimittelzusammensetzungen ermaessigter toxizitaet. - Google Patents
Arzneimittelzusammensetzungen ermaessigter toxizitaet.Info
- Publication number
- ATE65912T1 ATE65912T1 AT84902408T AT84902408T ATE65912T1 AT E65912 T1 ATE65912 T1 AT E65912T1 AT 84902408 T AT84902408 T AT 84902408T AT 84902408 T AT84902408 T AT 84902408T AT E65912 T1 ATE65912 T1 AT E65912T1
- Authority
- AT
- Austria
- Prior art keywords
- reduced toxicity
- medicinal compositions
- drug
- preparations
- toxicity
- Prior art date
Links
- 231100000419 toxicity Toxicity 0.000 title abstract 2
- 230000001988 toxicity Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 238000002360 preparation method Methods 0.000 abstract 3
- 239000003446 ligand Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60450384A | 1984-05-02 | 1984-05-02 | |
| PCT/US1984/000855 WO1985005030A1 (en) | 1984-05-02 | 1984-05-31 | Drug preparations of reduced toxicity |
| EP84902408A EP0180581B2 (de) | 1984-05-02 | 1984-05-31 | Arzneimittelzusammensetzungen ermässigter toxizität |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE65912T1 true ATE65912T1 (de) | 1991-08-15 |
Family
ID=24419861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84902408T ATE65912T1 (de) | 1984-05-02 | 1984-05-31 | Arzneimittelzusammensetzungen ermaessigter toxizitaet. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0180581B2 (de) |
| JP (1) | JP2506323B2 (de) |
| AT (1) | ATE65912T1 (de) |
| AU (1) | AU3063884A (de) |
| DE (1) | DE3484904D1 (de) |
| DK (1) | DK607885D0 (de) |
| FI (1) | FI860018A0 (de) |
| HK (1) | HK32492A (de) |
| PT (1) | PT78628B (de) |
| SG (1) | SG18792G (de) |
| WO (1) | WO1985005030A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409704A (en) * | 1985-06-26 | 1995-04-25 | The Liposome Company, Inc. | Liposomes comprising aminoglycoside phosphates and methods of production and use |
| IE60901B1 (en) * | 1986-08-21 | 1994-08-24 | Vestar Inc | Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
| US5043107A (en) * | 1986-08-21 | 1991-08-27 | Vestar Research, Inc. | Preparation small unilamellar vesicles including polyene antifungal antibiotics |
| US4822777A (en) * | 1987-02-27 | 1989-04-18 | Liposome Technology, Inc. | Amphotericin B/cholesterol sulfate composition |
| US6406713B1 (en) | 1987-03-05 | 2002-06-18 | The Liposome Company, Inc. | Methods of preparing low-toxicity drug-lipid complexes |
| US5616334A (en) * | 1987-03-05 | 1997-04-01 | The Liposome Company, Inc. | Low toxicity drug-lipid systems |
| AU598958B2 (en) | 1987-11-12 | 1990-07-05 | Vestar, Inc. | Improved amphotericin b liposome preparation |
| US4946683A (en) * | 1987-11-18 | 1990-08-07 | Vestar, Inc. | Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| CA2044663A1 (en) * | 1990-07-12 | 1992-01-13 | Makoto Tanaka | Water-dispersible polyene antifungal complexes |
| PT100486B (pt) * | 1992-05-14 | 1999-07-30 | Ineti Inst Nac Engenh E Tecnol | Aminoglucosidos lipossomais com altas eficacia de encapsulacao e actividade terapeutica, nomeadamente a netilmicina, e processo para a sua preparcao |
| JP2915296B2 (ja) * | 1993-08-30 | 1999-07-05 | 宇野 潤 | 抗真菌製剤 |
| WO1999027940A1 (en) * | 1997-12-01 | 1999-06-10 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Formulations for topical treatment of skin infections |
| WO2003002096A1 (en) | 2001-06-28 | 2003-01-09 | Wisconsin Alumni Research Foundation | Methods and compositions for polyene antibiotics with reduced toxicity |
| CN104856931B (zh) * | 2014-02-24 | 2019-06-18 | 石药集团中奇制药技术（石家庄）有限公司 | 一种两性霉素b纳米复合物及其制备方法 |
| CN116473985B (zh) * | 2023-03-29 | 2024-12-10 | 暨南大学 | 一种多烯类抗真菌药物组合物及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4119724A (en) * | 1973-11-26 | 1978-10-10 | Pepro | Fungicidal compositions containing phosphorous acid and derivatives thereof |
| TR19072A (tr) * | 1973-11-26 | 1978-05-01 | Pepro | Fosforlu tuerevler ihtiva eden fungisid terkipler |
| US3993754A (en) * | 1974-10-09 | 1976-11-23 | The United States Of America As Represented By The United States Energy Research And Development Administration | Liposome-encapsulated actinomycin for cancer chemotherapy |
| US4160827A (en) * | 1978-02-06 | 1979-07-10 | The Upjohn Company | Metronidazole phosphate and salts |
| US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| IL55431A (en) * | 1978-08-24 | 1982-07-30 | Yeda Res & Dev | Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them |
| DE2856333C2 (de) * | 1978-12-27 | 1983-09-22 | A. Nattermann & Cie GmbH, 5000 Köln | Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung |
| US4272525A (en) * | 1978-10-23 | 1981-06-09 | Schering Corporation | Derivatives of polyene macrolide antibiotics containing an amino sugar moiety, process for the preparation thereof, and pharmaceutical compositions containing them |
| GR73668B (de) * | 1978-11-21 | 1984-03-28 | Hoffmann La Roche | |
| GB2046092B (en) * | 1979-03-05 | 1983-11-02 | Toyama Chemical Co Ltd | Pharmaceutical composition containing a lysophospholid and a phospholipid |
| US4291027A (en) * | 1979-03-07 | 1981-09-22 | Engelhard Minerals & Chemicals Corp. | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes |
| US4291023A (en) * | 1979-03-07 | 1981-09-22 | Engelhard Minerals & Chemicals Corp. | Method for treating tumors using cis-diammineplatinum (II) organophosphate complexes |
| US4287187A (en) * | 1979-03-07 | 1981-09-01 | Engelhard Minerals & Chemicals Corporation | Method for treating tumors with cis-diammineplatinum(II) orthophosphate complexes |
| DE2914789A1 (de) * | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | Injizierbare arzneimittel mit entzuendungshemmender wirkung |
| CA1173360A (en) * | 1979-06-22 | 1984-08-28 | Jurg Schrank | Pharmaceutical preparations |
| DE2941384A1 (de) * | 1979-10-12 | 1981-04-23 | Bayer Ag, 5090 Leverkusen | Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2952115C2 (de) * | 1979-12-22 | 1982-05-06 | A. Nattermann & Cie GmbH, 5000 Köln | Rosmarinsäure-Phospholipid-Komplex |
| HU184141B (en) * | 1979-12-27 | 1984-07-30 | Human Oltoanyagtermelo | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
| US4430330A (en) * | 1980-02-29 | 1984-02-07 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering a phenothiazine and choline |
| US4346084A (en) * | 1980-02-29 | 1982-08-24 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering lithium and choline |
| JPS5793909A (en) * | 1980-12-03 | 1982-06-11 | Sankyo Co Ltd | Carcinostatic pharmaceutical having directivity to specific internal organ and its preparation |
| US4419348A (en) * | 1981-04-27 | 1983-12-06 | Georgetown University | Anthracycline glycoside compositions, their use and preparation |
| US4397846A (en) * | 1981-05-15 | 1983-08-09 | Murray Weiner | Storage-stable lipid vesicles and method of preparation |
-
1984
- 1984-05-22 PT PT78628A patent/PT78628B/pt unknown
- 1984-05-31 AU AU30638/84A patent/AU3063884A/en not_active Abandoned
- 1984-05-31 EP EP84902408A patent/EP0180581B2/de not_active Expired - Lifetime
- 1984-05-31 JP JP59502364A patent/JP2506323B2/ja not_active Expired - Lifetime
- 1984-05-31 AT AT84902408T patent/ATE65912T1/de not_active IP Right Cessation
- 1984-05-31 WO PCT/US1984/000855 patent/WO1985005030A1/en not_active Ceased
- 1984-05-31 DE DE8484902408T patent/DE3484904D1/de not_active Expired - Lifetime
-
1985
- 1985-12-30 DK DK607885A patent/DK607885D0/da not_active Application Discontinuation
-
1986
- 1986-01-02 FI FI860018A patent/FI860018A0/fi not_active Application Discontinuation
-
1992
- 1992-02-27 SG SG187/92A patent/SG18792G/en unknown
- 1992-04-30 HK HK324/92A patent/HK32492A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT78628B (en) | 1986-06-18 |
| WO1985005030A1 (en) | 1985-11-21 |
| JPS61502055A (ja) | 1986-09-18 |
| EP0180581B1 (de) | 1991-08-07 |
| JP2506323B2 (ja) | 1996-06-12 |
| FI860018A7 (fi) | 1986-01-02 |
| AU3063884A (en) | 1985-11-28 |
| SG18792G (en) | 1992-04-16 |
| DK607885A (da) | 1985-12-30 |
| PT78628A (en) | 1984-06-01 |
| EP0180581A1 (de) | 1986-05-14 |
| DK607885D0 (da) | 1985-12-30 |
| HK32492A (en) | 1992-05-08 |
| EP0180581A4 (de) | 1988-04-27 |
| EP0180581B2 (de) | 1995-12-20 |
| DE3484904D1 (de) | 1991-09-12 |
| FI860018A0 (fi) | 1986-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8603272A1 (es) | Procedimiento de producir un preparado de farmaco de toxicidad reducida | |
| ATE65912T1 (de) | Arzneimittelzusammensetzungen ermaessigter toxizitaet. | |
| DK203787A (da) | Praeparat til nasal administrering | |
| ES8201596A1 (es) | Procedimiento de obtencion de mucopolisacaridos | |
| ATE37028T1 (de) | Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte. | |
| NL190664C (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
| DE3580616D1 (de) | Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| FR2567885B1 (fr) | Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant | |
| NO870441L (no) | Farmasoeytiske preparatformer for stabilisering av alfa-interferon. | |
| ATE173627T1 (de) | Medizinische zusammensetzung | |
| ES8102141A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7 | |
| TNSN89039A1 (fr) | Tetrahydroimidazo(1,4)benzodiazepin-2-ones antivirales | |
| FI864164A7 (fi) | Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä. | |
| DE3867086D1 (de) | Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen. | |
| IT8423896A0 (it) | Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
| IT8219409A0 (it) | Derivati, tiolici dell'eritromicina ad attivita' terapeutica, relativo procedimento di preparazione e composizioni farmaceutiche che licontengono. | |
| ES2016052A6 (es) | Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico. | |
| ATE55254T1 (de) | Verminderung der toxischen wirkungen von anthrachinon-medikamenten. | |
| IT8520514A0 (it) | Composizioni di farmaci dotate di attivita' antimicrobica eprocedimento per la loro preparazione. | |
| FI850801A7 (fi) | Nitrodiaryylisulfoksi-johdannaisia, menetelmiä niiden valmistamiseksi ja niitä aktiivisena aineosana sisältäviä lääke- ja tuholaismyrkkyseok sia. | |
| OA08030A (fr) | Nouveaux dérivés de la quinoléine, leur préparation et compositions thérapeutiques en contenant. | |
| FR2567755B1 (fr) | Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene | |
| OA07999A (fr) | Nouveaux dérivés du bornane, leur préparation et compositions thérapeutiques en contenant. | |
| SE8704049D0 (sv) | Novel pharmacological compounds | |
| FR2453153A1 (fr) | Nouveau derive de dehydroproline, sa preparation et son application comme medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |